Observe customer behaviors and gather insights over short campaign iterations

Philippe Kirby

Digital Capabilites and Marketing Lead

MSD

Patients

Digital

AbbVie case study: Crush Your FOMO – empowering a nation to take control of its health

Hear how AbbVie is collaborating with experts from outside the health industry in a bold preventative health move. By putting open-data at the forefront, AbbVie will explore the value of leveraging real-life, data-driven insights to further understand complex human behaviour, in order to ultimately help build a more sustainable NHS.

Gwenan White

UK Director of Communications and Patient Relations

Abbvie

Commercial

DARE TO DARE: REDEFINE YOUR CUSTOMER APPROACH AND GET READY FOR TRANSFORMATION

Change your perspective. Engage with patients as the key decision makers they’re becoming, and empower them to make educated decisions about their own health.

Go deep to understand the patient journey and core customer needs. Do it well, and the insights can reveal hidden value pools, and possibly force you to change your company strategy

Meet the needs of your customers by applying relevant digital tools. Implement by applying a start-up way of working, and it will be rocket fuel for your strategy.

Christina Molt Wengel

Senior Vice President and Head of Global Marketing

ALK Pharmaceuticals

Digital

Commercial

Panel: Streamlining of customer experience with an omnichannel approach

Envision how an industry leading company has created a truly integrated omni-channel offering

Equip different departments to begin the omni-channel transition and ensure the required capabilities are in place

Tailor your marketing strategy to ensure alignment between various platforms to ensure a seamless, consistent and effortless user experience

Florent Edouard

SVP, Global Head of Commercial Excellence and Customer Engagement

Grünenthal Group

Philippe Kirby

Digital Capabilites and Marketing Lead

MSD

Patient Experience for Patient Centricity

Patients

Commercial

Patients

Commercial

Convince skeptics and prove the commercial value of a patient-centric approach

Obtain senior-level support for patient initiatives by linking efforts to outcomes

Simon Eade

Head Global Commercial Strategy

Actelion

Patients

Commercial

You can’t stand still- innovate into new areas of helping patients

Learn how Takeda Austria is taking steps to innovate STEM cell therapy and deliver much needed medicines to patients

Understand the implications needed to work together to deliver this 48-hour treatment and how Takeda is over coming these barriers

Kirsten Detrick

Head, Central Europe and Austria

Takeda

Gain traction and harness technology

Digital

Commercial

Digital

LEO Pharma – Growth Hacking their way to the top

Hear how LEO Pharma is hacking their way into better HCP engagement, the results and challenges

Understand not only the challenges of building the function and the business case for digital marketing

Kasper Jerlang

Head of Global Digital Marketing and Engagement

LEO Pharma

Digital

Commercial

The digitally mature sales function: how you can transform sales reps into catalysts

How real digital transformation will be dependent on capabilities of your customer-facing teams

Naji Gehchan

Chief Marketing Officer & Bio Medicines Leader - France

Eli Lilly

Digital

Commercial

The bottom-up approach to driving commercial digital transformation as a global team

Driving business change based on local business cases rather than a one-size-fits-all – with results

Practical applications of AI and automation to drive local business value

Working with all levels – from General Managers to Marketers - to change the ways of working

The hidden roadblocks and time saps in a true digital transformation

Lanre Ibitoye

Director , Head of Digital Platforms and Capabilites- Europe & International Markets

The Digitome: The first digital representation of health and disease

Understand the Human Digitome Project: long-term vision for the platform, including opening it up so that anyone can proactively use it themselves, so that researchers will understand more about how diseases work, and how to cure them.

How AI is being used to look for patterns in the ways patients contract diseases and react to medication, to give doctors more information about people’s health

Everything you need to know about The Human Cell Atlas, an ambitious project, funded by the Chan-Zuckerberg Institute and others, to map every cell in the human body and how this could impact how drugs are developed

Learn how the single revolution is rewriting our understanding of a human disease ranging from cancer to inflammatory conditions

Sam Behjati

Wellcome Trust Intermediate Clinical Fellow

Wellcome Sanger Institute

Health Tech & Innovation

Commercial

What commercial pharma needs to know about blockchain

Blockchain is about more than cryptocurrencies – it enables multiple parties to jointly collaborate and transact in near real-time

Records in the blockchain are encrypted and linked, addressing the heightened safety and privacy concerns that come with personalized care, patient registries & GDPR

Ben Taylor

CEO

LedgerDomain

Health Tech & Innovation

Two ways that blockchain can transform pharma

Live demo of a global supply chain application that passes medication from manufacturers to suppliers to patients – this not only sets the stage to drive down out-of-stocks and counterfeits, but also the advent of personalized medicines

Clinical study supply chains managed through blockchain make it possible to replace paper without compromising security or double-blind requirements

The first biopharma company to be born in the cloud

Understand how Moderna Therapeutics has evolved as a truly digital biopharma organization and what this means for advancing drug candidates to clinical studies; increasing the agility of its research, development, and manufacturing processes; and achieveing results—such as personalized cancer vaccines—that would have been impossible even a few years ago.

Lessons learnt from their journey and their vision for the future of the company and what this means for the future pharma business model

Marcello Damiani

CDO

Moderna Therapeutics

Health Tech & Innovation

Patients

Training our immune system to prevent and cure chronic diseases.

Understand that the prevention and management of chronic diseases should focus not only on symptomatic patients but on individuals that do not yet have symptoms.

Discuss how this disease-prevention strategy profoundly impacts clinical development, marketing and distribution of products, and new payor models.